XML 134 R108.htm IDEA: XBRL DOCUMENT v3.25.4
Schedule II - Cash Flows Financial Statement (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2025
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:                    
Net income (loss) $ 7,338 $ 2,417 $ 6,459 $ (1,623) $ 3,621 $ 2,790 $ 3,959 $ 4,542 $ 14,591 $ 14,912
Investment related gains (losses), net                 (140) 2,626
Federal income tax receivable                 (476) 1,398
Amortization of premiums and discounts on investments                 4,436 5,116
Depreciation                 741 619
Change in accrued investment income                 (695) (186)
Stock-based compensation                 2,774 1,517
Other, net                 (645) (1,414)
Net cash provided by operating activities                 17,986 31,918
Cash flows from investing activities:                    
Purchases of fixed maturity securities, available-for-sale                 (170,432) (84,412)
Maturities and calls of fixed maturities, available-for-sale                 40,573 51,234
Sales of fixed maturity securities, available-for-sale                 94,668 15,161
Purchases of property and equipment                 (447) (663)
Net cash used in investing activities                 (19,672) (27,173)
Cash flows from financing activities:                    
Other share repurchases                 (278) (393)
Net cash provided by financing activities                 (4,609) (2,471)
Net increase (decrease) in cash and cash equivalents                 (6,295) 2,274
Cash and cash equivalents at beginning of year       29,271       26,997 29,271 26,997
Cash and cash equivalents at end of year 22,976       29,271       22,976 29,271
Parent Company [Member]                    
Cash flows from operating activities:                    
Net income (loss)                 14,591 14,912
Investment related gains (losses), net                 (31) 17
Equity in income of consolidated subsidiaries                 (17,351) (15,996)
Accrued expenses and other liabilities                 210 4,303
Federal income tax receivable                 519 828
Amortization of premiums and discounts on investments                 54 81
Depreciation                 219 243
Change in accrued investment income                 38 32
Stock-based compensation                 2,774 1,517
Decrease (increase) in receivable from subsidiaries and other assets                 688 39
Other, net                 (222) (23)
Net cash provided by operating activities                 1,489 5,953
Cash flows from investing activities:                    
Purchases of fixed maturity securities, available-for-sale                 (8,820) (5,066)
Maturities and calls of fixed maturities, available-for-sale                 4,671 9,989
Purchases of equity securities                 (120) 0
Sales of fixed maturity securities, available-for-sale                 4,444 0
Purchases of property and equipment                 0 (106)
Net cash used in investing activities                 175 4,817
Cash flows from financing activities:                    
Capital contribution to subsidiary                 0 (10,010)
Other share repurchases                 (278) (393)
Net cash provided by financing activities                 (278) (10,403)
Net increase (decrease) in cash and cash equivalents                 1,386 367
Cash and cash equivalents at beginning of year       $ 4,272       $ 3,905 4,272 3,905
Cash and cash equivalents at end of year $ 5,658       $ 4,272       $ 5,658 $ 4,272